Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study

Autor:	Linhart, Aleš, Dostalova, Gabriela, Nicholls, Kathy, West, Michael, Tøndel, Camilla, Jovanovic, Ana, Giraldo, Pilar, Vujkovac, Bojan, Geberhiwot, T, Brill-Almon, Einat, Alon, Sari, Chertkoff, Raul, Rocco, Rossana, Hughes, Derralynn A.
Databáze:	NORA (Norwegian Open Research Archive)
Externí odkaz:	https://hdl.handle.net/11250/3122371 Zobrazit plný text záznamu